Aquestive Therapeutics, Inc. Sued Over Alleged Concealed NDA Deficiencies Impacting Investors Investors in Aquestive Therapeutics are facing significant losses due to alleged undisclosed deficiencies related to its Anaphylm NDA. A lawsuit has been filed to address these concerns.

Aquestive Therapeutics, Inc. Sued Over Alleged Concealed NDA Deficiencies Impacting Investors #United_States #New_York #Lawsuit #Aquestive_Therapeutics #Anaphylm_NDA